AmpliPhage-004

N/A

Report date: 2025/10/23 17:53:53

Base Information

Drug NameAmpliPhage-004
Drug Alias Namebacteriophage based antibiotic (AmpliPhi)bacteriophage therapy (University of Leicester/AmpliPhi BioSciences)AB-CD01AmpliPhage-004
ClassificationBiologics > Bacteriophages
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGastrointestinal DiseasesClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Leicester
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of LeicesterArmata Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsGastrointestinal DiseasesClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A